Clinuvel Pharmaceuticals Ltd
OTC:CLVLY

Watchlist Manager
Clinuvel Pharmaceuticals Ltd Logo
Clinuvel Pharmaceuticals Ltd
OTC:CLVLY
Watchlist
Price: 8.15 USD -0.73%
Market Cap: 420.4m USD

Wall Street
Price Targets

CLVLY Price Targets Summary
Clinuvel Pharmaceuticals Ltd

Wall Street analysts forecast CLVLY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLVLY is 16.9 USD with a low forecast of 9.1 USD and a high forecast of 28.28 USD.

Lowest
Price Target
9.1 USD
12% Upside
Average
Price Target
16.9 USD
107% Upside
Highest
Price Target
28.28 USD
247% Upside
Clinuvel Pharmaceuticals Ltd Competitors:
Price Targets
LTRN
Lantern Pharma Inc.
505% Upside
NGNE
Neurogene Inc
197% Upside
RIGL
Rigel Pharmaceuticals Inc
9% Upside
KURN
Kuros Biosciences AG
24% Upside
ZBIO
Zenas Biopharma Inc
41% Upside
XGN
Exagen Inc
124% Upside
GBIO
Generation Bio Co
474% Upside
RCKT
Rocket Pharmaceuticals Inc
132% Upside

Revenue
Forecast

Revenue Estimate
Clinuvel Pharmaceuticals Ltd

For the last 13 years the compound annual growth rate for Clinuvel Pharmaceuticals Ltd's revenue is 39%. The projected CAGR for the next 3 years is 15%.

39%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Clinuvel Pharmaceuticals Ltd

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's operating income for the next 3 years is 13%.

N/A
Past Growth
13%
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
Clinuvel Pharmaceuticals Ltd

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's net income for the next 3 years is 17%.

N/A
Past Growth
17%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLVLY's stock price target?
Price Target
16.9 USD

According to Wall Street analysts, the average 1-year price target for CLVLY is 16.9 USD with a low forecast of 9.1 USD and a high forecast of 28.28 USD.

What is Clinuvel Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
15%

For the last 13 years the compound annual growth rate for Clinuvel Pharmaceuticals Ltd's revenue is 39%. The projected CAGR for the next 3 years is 15%.

What is Clinuvel Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
13%

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's operating income for the next 3 years is 13%.

What is Clinuvel Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
17%

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's net income for the next 3 years is 17%.

Back to Top